Viewing Study NCT02331251


Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2026-02-17 @ 4:43 PM
Study NCT ID: NCT02331251
Status: TERMINATED
Last Update Posted: 2018-07-02
First Post: 2015-01-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)
Sponsor: Western Regional Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: PembroPlus
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators